Demars Financial Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-9,961
| Closed | -$1.34M | – | 74 |
|
|
2023
Q2 | $1.34M | Sell |
9,961
-563
| -5% | -$75.9K | 0.75% | 32 |
|
|
2023
Q1 | $1.68M | Sell |
10,524
-980
| -9% | -$156K | 0.92% | 26 |
|
|
2022
Q4 | $1.86M | Sell |
11,504
-962
| -8% | -$155K | 1.03% | 28 |
|
|
2022
Q3 | $1.67M | Buy |
12,466
+5,020
| +67% | +$674K | 0.99% | 29 |
|
|
2022
Q2 | $1.14M | Sell |
7,446
-2,200
| -23% | -$337K | 0.65% | 39 |
|
|
2022
Q1 | $1.56M | Sell |
9,646
-450
| -4% | -$73K | 0.79% | 33 |
|
|
2021
Q4 | $1.37M | Buy |
10,096
+6,783
| +205% | +$918K | 0.72% | 38 |
|
|
2021
Q3 | $357K | Sell |
3,313
-576
| -15% | -$62.1K | 0.21% | 66 |
|
|
2021
Q2 | $438K | Buy |
3,889
+100
| +3% | +$11.3K | 0.26% | 60 |
|
|
2021
Q1 | $410K | Sell |
3,789
-10
| -0.3% | -$1.08K | 0.28% | 58 |
|
|
2020
Q4 | $407K | Sell |
3,799
-25
| -0.7% | -$2.68K | 0.29% | 53 |
|
|
2020
Q3 | $335K | Buy |
3,824
+254
| +7% | +$22.3K | 0.26% | 48 |
|
|
2020
Q2 | $351K | Buy |
3,570
+135
| +4% | +$13.3K | 0.29% | 45 |
|
|
2020
Q1 | $262K | Buy |
+3,435
| New | +$262K | 0.27% | 43 |
|